Correlation Between Corcept Therapeutics and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corcept Therapeutics and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corcept Therapeutics and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corcept Therapeutics Incorporated and Halozyme Therapeutics, you can compare the effects of market volatilities on Corcept Therapeutics and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corcept Therapeutics with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corcept Therapeutics and Halozyme Therapeutics.
Diversification Opportunities for Corcept Therapeutics and Halozyme Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Corcept and Halozyme is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Corcept Therapeutics Incorpora and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Corcept Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corcept Therapeutics Incorporated are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Corcept Therapeutics i.e., Corcept Therapeutics and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between Corcept Therapeutics and Halozyme Therapeutics
Given the investment horizon of 90 days Corcept Therapeutics Incorporated is expected to generate 1.91 times more return on investment than Halozyme Therapeutics. However, Corcept Therapeutics is 1.91 times more volatile than Halozyme Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 7,433 in Corcept Therapeutics Incorporated on September 11, 2025 and sell it today you would earn a total of 887.00 from holding Corcept Therapeutics Incorporated or generate 11.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corcept Therapeutics Incorpora vs. Halozyme Therapeutics
Performance |
| Timeline |
| Corcept Therapeutics |
| Halozyme Therapeutics |
Corcept Therapeutics and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corcept Therapeutics and Halozyme Therapeutics
The main advantage of trading using opposite Corcept Therapeutics and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corcept Therapeutics position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.| Corcept Therapeutics vs. Halozyme Therapeutics | Corcept Therapeutics vs. Abivax SA American | Corcept Therapeutics vs. Rhythm Pharmaceuticals | Corcept Therapeutics vs. Merus BV |
| Halozyme Therapeutics vs. Corcept Therapeutics Incorporated | Halozyme Therapeutics vs. Abivax SA American | Halozyme Therapeutics vs. Rhythm Pharmaceuticals | Halozyme Therapeutics vs. Cytokinetics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |